Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Spark licenses blindness gene therapy rights outside U.S. to Novartis
Yahoo/Reuters
Thu, 01/25/18 - 12:00 am
Tags:
Spark Therapeutics, Novartis, Luxturna, gene therapy
Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto
NASDAQ.com
Wed, 01/24/18 - 08:10 pm
Tags:
Novartis, earnings, Cosentyx, Entresto
Big day looming, Novartis’ new CEO Vas Narasimhan readies his jump into a marketing melee
Endpoints
Wed, 01/24/18 - 09:16 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, Joe Jimenez
Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.
Fierce Pharma
Mon, 01/22/18 - 05:41 pm
Tags:
Novartis, Arzerra, Genmab, CLL, chronic lymphocytic leukemia
Novartis ties a new round of biosimilar development programs to a partnership deal with India’s Biocon
Endpoints
Thu, 01/18/18 - 10:35 pm
Tags:
Novartis, Biocon, drug development, biosimilars
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Tags:
Novartis, Humira, biosimilars, AbbVie, Sandoz
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Tags:
Novartis, JNJ, psoriasis, Cosentyx, Stelara
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Tags:
Novartis, psoriasis, Cosentyx, biosimilars, ankylosing spondylitis
Novartis Pharma Ex-CEO takes three roles in two days
Pharmafile
Sat, 01/6/18 - 12:36 pm
Tags:
Novartis, Pharma CEOs, David Epstein, Axcella Health, Rubius
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
Tags:
cancer, Merck, Japan, Keytruda, Seattle Genetics, Adcetris, Novartis, Kisqali
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Fierce Pharma
Thu, 01/4/18 - 10:27 pm
Tags:
drug pricing, Pfizer, Novartis, AbbVie
Novartis Gets Second Breakthrough Designation for Kisqali
Yahoo/Zacks.com
Thu, 01/4/18 - 09:50 pm
Tags:
Novartis, Kisqali, breast cancer
Top 10 stories that had pharma execs talking
Biopharma Dive
Thu, 01/4/18 - 12:02 pm
Tags:
M&A, Bristol-Myers Squibb, Opdivo, Express Scripts, Novartis, C-ART, Kymriah, Massachusetts, AbbVie, Kenneth Frazier, biosimilars, CVS Health Pfizer
Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels
RAPS.org
Sat, 12/23/17 - 11:58 am
Tags:
Novartis, generics, California
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Endpoints
Thu, 12/21/17 - 10:12 am
Tags:
Kymriah, Yescarta, CAR-T, Novartis, Kite Pharma, Gilead Sciences, drug pricing
P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
Fierce Pharma
Tue, 12/19/17 - 10:20 am
Tags:
P&G, Novartis, Pharma CEOs, Joe Jimenez
What’s the big hurry Novartis? Pharma giant scores a PRV shortcut for $130M
Endpoints
Mon, 12/18/17 - 10:02 am
Tags:
Novartis, priority review vouchers, Ultragenyx
Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval
Fierce Pharma
Fri, 12/15/17 - 11:27 pm
Tags:
Pfizer, Novartis, Eli Lilly, Xeljanz, psoriatic arthritis
Novartis oncology CEO Bruno Strigini is calling it quits
Endpoints
Fri, 12/15/17 - 10:09 am
Tags:
Novartis, oncology, Bruno Strigini
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
Tags:
ASH17, Biomarin, Spark Therapeutics, Gilead Sciences, Novartis, Juno Therapeutics, AbbVie, Roche, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.